{"id":"continue-current-regimen","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Continue current regimen","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T06:02:45.616477+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Continue current regimen","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T06:03:01.880850+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108543/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:03:02.364430+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-27T23:43:45.720Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:03:04.164305+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07496528","phase":"NA","title":"Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-04-01","conditions":"Colorectal Neoplasms, Ileus Postoperative, Postoperative Complication","enrollment":240},{"nctId":"NCT07285460","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-12-18","conditions":"Hemophilia","enrollment":85},{"nctId":"NCT05034432","phase":"PHASE4","title":"The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2022-05-27","conditions":"Arrythmia, Cardiomyopathies","enrollment":100},{"nctId":"NCT07426055","phase":"PHASE2, PHASE3","title":"PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer","status":"RECRUITING","sponsor":"Affidea Nu-med Center of Oncological DIagnostics and Therapy","startDate":"2026-03-19","conditions":"Prostate Cancer (Adenocarcinoma), Prostate Brachytherapy, Stereotactic Body Radiation Therapy (SBRT)","enrollment":1200},{"nctId":"NCT06568549","phase":"PHASE4","title":"Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-06-13","conditions":"Kidney Transplantation, Mycophenolate Mofetil","enrollment":350},{"nctId":"NCT06998524","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-06-27","conditions":"Von Willebrand Disease, Type 3","enrollment":75},{"nctId":"NCT07480707","phase":"NA","title":"Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?","status":"NOT_YET_RECRUITING","sponsor":"Fatty Acid Research Institute","startDate":"2026-05-01","conditions":"Omega-3 Fatty Acids","enrollment":48},{"nctId":"NCT03486873","phase":"PHASE3","title":"Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-08-21","conditions":"Solid Tumors, Hematologic Malignancies","enrollment":3500},{"nctId":"NCT04582383","phase":"PHASE4","title":"Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-03-30","conditions":"Acne","enrollment":350},{"nctId":"NCT07441382","phase":"NA","title":"Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-01","conditions":"Atrial Fibrillation (AF), Stroke, Hemorrhage","enrollment":200},{"nctId":"NCT07209267","phase":"PHASE2","title":"Baricitinib Curative Repression of HIV-1","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"HIV Infection, HIV","enrollment":20},{"nctId":"NCT06675955","phase":"PHASE3","title":"An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2024-12-13","conditions":"Multiple Sclerosis","enrollment":500},{"nctId":"NCT05836987","phase":"PHASE3","title":"The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-07-13","conditions":"Atrial Fibrillation","enrollment":5350},{"nctId":"NCT07399145","phase":"NA","title":"Comparison of Prolotherapy and Rehabilitation Treatments in Low Back Pain (CPRTLBP)","status":"COMPLETED","sponsor":"Balnear and Rehabilitation Sanatorium Techirghiol","startDate":"2025-04-01","conditions":"Low Back Pain","enrollment":84},{"nctId":"NCT07385989","phase":"PHASE2","title":"Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"WEI XU","startDate":"2026-01-25","conditions":"Extranodal NK/T-cell Lymphoma","enrollment":40},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT05287568","phase":"PHASE1","title":"CC-486 and Venetoclax for Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-12-19","conditions":"AML","enrollment":35},{"nctId":"NCT06928922","phase":"EARLY_PHASE1","title":"Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-02-24","conditions":"Advanced Lung Cancer, Lung Metastasis","enrollment":83},{"nctId":"NCT05354869","phase":"NA","title":"Transvaginal Electrical Stimulation for Myofascial Pelvic Pain","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-10-31","conditions":"Myofascial Pelvic Pain","enrollment":60},{"nctId":"NCT02951052","phase":"PHASE3","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":618},{"nctId":"NCT07307443","phase":"PHASE2","title":"A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Zhijie Wang","startDate":"2026-02-01","conditions":"SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Lung Cancer","enrollment":28},{"nctId":"NCT07260266","phase":"NA","title":"Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Opioid Consumption in Patients Undergoing Major Abdominal Surgery","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Jiaxing University","startDate":"2026-01-01","conditions":"Pain Management","enrollment":108},{"nctId":"NCT06952920","phase":"PHASE3","title":"Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2025-08-21","conditions":"Standard Quadruple Antiemetic Therapy, Electroacupuncture, Chemotherapy-induced Gastrointestinal Symptom Cluster","enrollment":388},{"nctId":"NCT05122767","phase":"PHASE1, PHASE2","title":"Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Aurum Institute NPC","startDate":"2023-05-24","conditions":"Tuberculosis, HIV","enrollment":92},{"nctId":"NCT05630872","phase":"PHASE2","title":"Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-02-13","conditions":"HIV-associated Tuberculosis","enrollment":30},{"nctId":"NCT05114213","phase":"PHASE2","title":"MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC","status":"TERMINATED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2021-12-15","conditions":"Pancreatic Cancer","enrollment":9},{"nctId":"NCT05106036","phase":"NA","title":"Preventing Cognitive Decline by Reducing BP Target Trial","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-07-11","conditions":"Cognitive Decline, Blood Pressure, Hypertension","enrollment":4000},{"nctId":"NCT07245342","phase":"NA","title":"Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2025-11-25","conditions":"Prostate Cancer","enrollment":216},{"nctId":"NCT05818605","phase":"NA","title":"Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-02-17","conditions":"Hypertrophic Cardiomyopathy","enrollment":70},{"nctId":"NCT07030920","phase":"PHASE2","title":"Reducing Systemic Inflammation in People on Antiretroviral Therapy","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-09-30","conditions":"Human Immunodeficiency Virus (HIV), Cardiovascular Risk Factor","enrollment":150},{"nctId":"NCT07234487","phase":"PHASE2","title":"Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL","status":"RECRUITING","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2024-10-14","conditions":"Hodgkin Lymphoma","enrollment":178},{"nctId":"NCT03229200","phase":"PHASE4","title":"Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pharmacyclics Switzerland GmbH","startDate":"2017-05-22","conditions":"Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell","enrollment":297},{"nctId":"NCT06174987","phase":"PHASE3","title":"A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)","status":"RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2024-01-05","conditions":"Advanced Cancer, Metastatic Cancer","enrollment":50},{"nctId":"NCT05502341","phase":"PHASE2, PHASE3","title":"Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2022-08-16","conditions":"HIV-1-infection","enrollment":689},{"nctId":"NCT02414269","phase":"PHASE1, PHASE2","title":"Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-05","conditions":"Malignant Pleural Disease, Mesothelioma, Metastases","enrollment":113},{"nctId":"NCT07193277","phase":"PHASE4","title":"Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-09-01","conditions":"Focal Epilepsy, Cognitive Impairment","enrollment":220},{"nctId":"NCT05488366","phase":"EARLY_PHASE1","title":"Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2022-08-03","conditions":"Sarcoma, Soft Tissue","enrollment":9},{"nctId":"NCT06964464","phase":"PHASE4","title":"Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2025-08-17","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death, Ventricular Arrhythmia","enrollment":2000},{"nctId":"NCT05823571","phase":"PHASE1","title":"Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-07-06","conditions":"Leukemia, Acute, Myelodysplastic Syndromes, Myelomonocytic Leukemia, Chronic","enrollment":32},{"nctId":"NCT04592744","phase":"PHASE4","title":"Angiotensin 2 for AKI After OLT","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Los Angeles","startDate":"2022-04-08","conditions":"Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury","enrollment":30},{"nctId":"NCT07164690","phase":"PHASE2","title":"Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-09","conditions":"Esophageal Adenocarcinoma, Radiotherapy","enrollment":32},{"nctId":"NCT07139483","phase":"NA","title":"Preventing Chronification of Phantom Limb Pain Through Mirror Therapy in Conjunction With tDCS","status":"RECRUITING","sponsor":"University of Haifa","startDate":"2025-03-25","conditions":"Phantom Limb Pain After Amputation","enrollment":108},{"nctId":"NCT06798324","phase":"PHASE4","title":"tDCS Plus Varenicline for Smoking Cessation","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2025-03-10","conditions":"Nicotine Dependence, Tobacco Smoking, Smoking Cessation","enrollment":160},{"nctId":"NCT06841172","phase":"PHASE3","title":"Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2025-07-21","conditions":"OligoProgressive Metastatic Disease, Hepatocellular Carcinoma (HCC), Radiotherapy","enrollment":132},{"nctId":"NCT06336434","phase":"PHASE1, PHASE2","title":"CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-05-01","conditions":"HIV-1-infection, Pregnancy, Postpartum","enrollment":""},{"nctId":"NCT05303493","phase":"PHASE1","title":"Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma","status":"COMPLETED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2022-06-29","conditions":"NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma","enrollment":45},{"nctId":"NCT06889025","phase":"NA","title":"Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen","status":"NOT_YET_RECRUITING","sponsor":"Felicia Iftene","startDate":"2025-07-24","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":28},{"nctId":"NCT04411420","phase":"NA","title":"Improving Veteran Access to Integrated Management of Back Pain","status":"COMPLETED","sponsor":"Duke University","startDate":"2021-03-08","conditions":"Low Back Pain, Veterans Family","enrollment":1817},{"nctId":"NCT02285114","phase":"PHASE2, PHASE3","title":"Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2015-01-20","conditions":"HIV-1","enrollment":41},{"nctId":"NCT06928519","phase":"","title":"Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study","status":"RECRUITING","sponsor":"Yousheng Xiao","startDate":"2025-06-05","conditions":"Parkinson Disease (PD)","enrollment":216},{"nctId":"NCT07019272","phase":"","title":"Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study","status":"NOT_YET_RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2025-06-30","conditions":"HER2-positive Breast Cancer","enrollment":170},{"nctId":"NCT06074185","phase":"PHASE2","title":"Treating Respiratory Emergencies in Children Study","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2024-02-19","conditions":"Asthma in Children","enrollment":44},{"nctId":"NCT04338321","phase":"PHASE3","title":"A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2020-08-21","conditions":"Depressive Disorder, Major","enrollment":676},{"nctId":"NCT02406027","phase":"PHASE2","title":"An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-07-02","conditions":"Alzheimer Disease","enrollment":90},{"nctId":"NCT05361148","phase":"","title":"Long-term Health After Severe Acute Malnutrition in Children and Adults: the Role of the Pancreas","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-01-12","conditions":"Pancreas Atrophy, Diabetes, Malnutrition","enrollment":2305},{"nctId":"NCT06583993","phase":"EARLY_PHASE1","title":"A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients","status":"RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2024-11-07","conditions":"Intrahepatic Cholangiocarcinoma","enrollment":9},{"nctId":"NCT06418659","phase":"EARLY_PHASE1","title":"A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients","status":"RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2024-10-12","conditions":"Advanced Hepatocellular Carcinoma","enrollment":37},{"nctId":"NCT05044962","phase":"NA","title":"Kuwa Free! - Live Free!","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2021-11-26","conditions":"HIV Infections, Contraception, Drug-drug Interaction","enrollment":700},{"nctId":"NCT03903835","phase":"PHASE3","title":"ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2019-02-01","conditions":"Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)","enrollment":750},{"nctId":"NCT05414331","phase":"NA","title":"WithDRawal Impact Of Postoperative Beta-Blocker","status":"TERMINATED","sponsor":"Yale University","startDate":"2022-11-04","conditions":"Coronary Artery Bypass","enrollment":43},{"nctId":"NCT03945747","phase":"","title":"MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2019-08-14","conditions":"Type1 Diabetes Mellitus, Diabetes Mellitus, Type 1, Autoimmune Diabetes","enrollment":50},{"nctId":"NCT04442737","phase":"PHASE4","title":"A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain","status":"COMPLETED","sponsor":"Janssen Scientific Affairs, LLC","startDate":"2020-07-01","conditions":"HIV-1","enrollment":103},{"nctId":"NCT05116774","phase":"PHASE2","title":"BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy","status":"TERMINATED","sponsor":"BioCryst Pharmaceuticals","startDate":"2021-12-06","conditions":"Paroxysmal Nocturnal Hemoglobinuria (PNH)","enrollment":12},{"nctId":"NCT06810388","phase":"NA","title":"Impact of Family-Centered Empowerment on Caregivers of Children with Cancer: a Quasi-Experimental Study Protocol","status":"NOT_YET_RECRUITING","sponsor":"Xiaowan Li","startDate":"2025-07-01","conditions":"Malignant Tumor","enrollment":128},{"nctId":"NCT04451772","phase":"PHASE2","title":"A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-07-27","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":185},{"nctId":"NCT05349838","phase":"PHASE3","title":"Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N","status":"COMPLETED","sponsor":"NEAT ID Foundation","startDate":"2018-11-05","conditions":"HIV-1-infection","enrollment":140},{"nctId":"NCT05289986","phase":"PHASE4","title":"The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients","status":"TERMINATED","sponsor":"Chelsea and Westminster NHS Foundation Trust","startDate":"2023-11-21","conditions":"Hiv","enrollment":18},{"nctId":"NCT06350474","phase":"NA","title":"Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study","status":"COMPLETED","sponsor":"Nicole Hamblett","startDate":"2020-08-25","conditions":"Cystic Fibrosis","enrollment":477},{"nctId":"NCT03282019","phase":"NA","title":"Study of Long-term HFNC for COPD Patients with HOT","status":"COMPLETED","sponsor":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","startDate":"2017-09-06","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":120},{"nctId":"NCT06684392","phase":"NA","title":"Assessment of the Effect of an Inspiratory Muscle Training Regimen on Decannulation Time in Tracheostomized Subjects","status":"RECRUITING","sponsor":"Hospital Dr. Franco Ravera Zunino","startDate":"2023-11-01","conditions":"Tracheostomy Complication, Diaphragm Disease","enrollment":56},{"nctId":"NCT05286632","phase":"NA","title":"KidneYou - Innovative Digital Therapy","status":"COMPLETED","sponsor":"Advice Pharma Group srl","startDate":"2022-07-18","conditions":"Chronic Kidney Diseases, Diabetes, Arterial Hypertension","enrollment":210},{"nctId":"NCT03653832","phase":"PHASE3","title":"Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial)","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2018-12-10","conditions":"Critical Illness","enrollment":1437},{"nctId":"NCT06624943","phase":"PHASE4","title":"Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali","status":"COMPLETED","sponsor":"Life for a Child Program, Diabetes Australia","startDate":"2022-03-14","conditions":"Type 1 Diabetes (T1D)","enrollment":260},{"nctId":"NCT03164655","phase":"PHASE2","title":"Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2018-07-25","conditions":"Colorectal Cancer Metastatic","enrollment":20},{"nctId":"NCT06350461","phase":"NA","title":"Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study","status":"COMPLETED","sponsor":"Nicole Hamblett","startDate":"2020-08-25","conditions":"Cystic Fibrosis","enrollment":370},{"nctId":"NCT05394766","phase":"NA","title":"Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-07-29","conditions":"Hypertension","enrollment":550},{"nctId":"NCT04100083","phase":"PHASE4","title":"Spironolactone for Hidradenitis Suppurativa","status":"WITHDRAWN","sponsor":"Medical University of South Carolina","startDate":"2020-09-21","conditions":"Hidradenitis Suppurativa","enrollment":""},{"nctId":"NCT05983211","phase":"NA","title":"Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-05-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":15},{"nctId":"NCT04320602","phase":"PHASE4","title":"Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2021-04-14","conditions":"Paroxysmal Nocturnal Hemoglobinuria","enrollment":18},{"nctId":"NCT02429791","phase":"PHASE3","title":"Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2015-04-14","conditions":"HIV Infections","enrollment":510},{"nctId":"NCT02422797","phase":"PHASE3","title":"Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2015-04-21","conditions":"HIV Infections","enrollment":518},{"nctId":"NCT00789945","phase":"NA","title":"Timing of Insulin Before Meals Everyday","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2008-12","conditions":"Type 1 Diabetes","enrollment":76},{"nctId":"NCT03421743","phase":"PHASE2","title":"Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection","status":"COMPLETED","sponsor":"Savara Inc.","startDate":"2018-03-01","conditions":"Mycobacterium Infections, Nontuberculous","enrollment":32},{"nctId":"NCT05684627","phase":"NA","title":"The Application of a Fasting- Mimicking Diet in Periodontitis: A Feasibility Study","status":"COMPLETED","sponsor":"Akdeniz University","startDate":"2023-03-15","conditions":"Periodontitis","enrollment":20},{"nctId":"NCT03639311","phase":"PHASE2","title":"Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2018-09-24","conditions":"HIV Infections","enrollment":97},{"nctId":"NCT03911973","phase":"PHASE1, PHASE2","title":"Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kari Wisinski","startDate":"2019-04-17","conditions":"TNBC - Triple-Negative Breast Cancer","enrollment":37},{"nctId":"NCT05243602","phase":"PHASE4","title":"BFTAF Elderly Switch Study","status":"COMPLETED","sponsor":"University of Nairobi","startDate":"2022-02-01","conditions":"HIV-1-infection","enrollment":520},{"nctId":"NCT06320626","phase":"PHASE4","title":"Pharmacokinetic-guided Dosing of Emicizumab","status":"RECRUITING","sponsor":"Kathelijn Fischer","startDate":"2022-09-08","conditions":"Hemophilia A With Inhibitor, Hemophilia A Without Inhibitor, Hemophilia A, Severe","enrollment":95},{"nctId":"NCT03727152","phase":"PHASE3","title":"Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2019-05-01","conditions":"HIV","enrollment":170},{"nctId":"NCT06238583","phase":"","title":"Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors","status":"NO_LONGER_AVAILABLE","sponsor":"Bayer","startDate":"","conditions":"Cancer","enrollment":""},{"nctId":"NCT02496156","phase":"NA","title":"Shared Medical Decision Making in Pediatric Diabetes","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2015-02","conditions":"Type 1 Diabetes Mellitus","enrollment":153},{"nctId":"NCT06236360","phase":"NA","title":"Metastatic Melanoma Patients on Immunotherapy With Nutritive Intervention Based on Mediterranean Diet","status":"UNKNOWN","sponsor":"University Hospital Rijeka","startDate":"2023-12-21","conditions":"Melanoma Stage Iv, Metastatic Melanoma","enrollment":30},{"nctId":"NCT06226740","phase":"NA","title":"Effectiveness of Different Obturation Techniques","status":"COMPLETED","sponsor":"Abant Izzet Baysal University","startDate":"2021-09-17","conditions":"Apical Periodontitis, Postoperative Pain, Endodontically Treated Teeth","enrollment":63},{"nctId":"NCT02687464","phase":"NA","title":"Appendectomy Versus Non-Operative Treatment For Acute Non-Perforated Appendicitis in Children","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2016-01-20","conditions":"Appendicitis","enrollment":978},{"nctId":"NCT03529513","phase":"","title":"Medibio DDA Confirmatory Performance Study","status":"COMPLETED","sponsor":"Medibio Limited","startDate":"2017-08-18","conditions":"Major Depressive Episode","enrollment":234},{"nctId":"NCT04347330","phase":"NA","title":"Cardiovascular Risk Reduction in Atrial Fibrillation Trial","status":"UNKNOWN","sponsor":"Beijing Anzhen Hospital","startDate":"2020-08-31","conditions":"Atrial Fibrillation, Hypertension","enrollment":1675},{"nctId":"NCT02549092","phase":"PHASE3","title":"A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2015-10-26","conditions":"Advanced Parkinson's Disease","enrollment":89},{"nctId":"NCT03422627","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease","status":"TERMINATED","sponsor":"Amgen","startDate":"2018-04-27","conditions":"Chronic Graft Versus Host Disease cGVHD","enrollment":32},{"nctId":"NCT05887037","phase":"NA","title":"Economic Impact of mNGS on Diagnosis of Post-neurosurgical Central Nervous System Infection","status":"UNKNOWN","sponsor":"Jian-Xin Zhou","startDate":"2022-07-01","conditions":"Central Nervous System Infections","enrollment":204},{"nctId":"NCT04892654","phase":"PHASE3","title":"Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch","status":"RECRUITING","sponsor":"Chelsea and Westminster NHS Foundation Trust","startDate":"2022-08-17","conditions":"HIV-1-infection","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2108543"},"_approvalHistory":[],"publicationCount":60,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Control"],"phase":"marketed","status":"active","brandName":"Continue current regimen","genericName":"Continue current regimen","companyName":"University of Nairobi","companyId":"university-of-nairobi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":2,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:03:04.164305+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}